Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report

3Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

After more than a year of Coronavirus disease 2019 pandemic, in 2021 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccination have been made possible and vaccine was distributed globally. Since then, there have been reports of symptoms following SARS-CoV-2 vaccination, including neurological symptoms of ascending paralysis known as Guillain-Barre syndrome. In this report, we describe the first case of Guillain-Barre syndrome following vaccination in Indonesia. Symptoms of ascending paralysis were of late onset after the first dose, however, were full blown after receiving the second dose followed by left-sided facial paralysis.

Cite

CITATION STYLE

APA

Gunawan, P. Y., Tiffani, P., & Lalisang, L. (2022). Guillain-Barre Syndrome Following SARS-CoV-2 Vaccination: A Case Report. Clinical Psychopharmacology and Neuroscience, 20(4), 777–780. https://doi.org/10.9758/CPN.2022.20.4.777

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free